Trump Reciprocal Tariffs: Gland Pharma shares in focus after sector gets exemption for now

Share it

The US has imposed a 26% reciprocal tariff on India, though certain sectors, including pharmaceuticals, are currently exempt.

Leave a Comment

Your email address will not be published. Required fields are marked *